NDC Compounded Drug 26436-5638-1 Tetracaine; Lidocaine; Phenylephrine Hydrochloride

Ointment Topical

Table of Contents

    1. Compounded Product Information
    2. NDC Crossover Products Matching Lidocaine/tetracaine/ Phenylephrine Hcl 23%/7%/0.5%
    3. Frequently Asked Questions

Compounded Drug Product Information

NDC Product Code 26436-5638
NDC Package Code 26436-5638-1
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.		 26436563801
Package Description 120 g in 1 CONTAINER
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.		 Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.		 Lidocaine/tetracaine/ Phenylephrine Hcl 23%/7%/0.5%
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.		 Lidocaine/tetracaine/ Phenylephrine Hcl 23/7/0.5
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.		 Tetracaine; Lidocaine; Phenylephrine Hydrochloride
Dosage Form Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Route Name Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 26436
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.		 Hybrid Pharma
Substance Name Tetracaine; Lidocaine; Phenylephrine Hydrochloride
Active Ingredients Information 70 mg/1 g; 230 mg/1 g; 5 mg/1 g
Reporting Period 2025-1

NDC Crossover Products Matching Tetracaine; Lidocaine; Phenylephrine Hydrochloride

NDC crossover of Lidocaine/tetracaine/ Phenylephrine Hcl 23%/7%/0.5% with NDC 26436-5638 a human compounded drug with other similar products matching the same substance name (Tetracaine; Lidocaine; Phenylephrine Hydrochloride) and the same administration route (topical) or dosage form (ointment).

Frequently Asked Questions

What is the NDC number assigned to Lidocaine/tetracaine/ Phenylephrine Hcl 20%/7%/0.5%?

Lidocaine/tetracaine/ Phenylephrine Hcl 20%/7%/0.5% was assigned by its manufacturer with NDC product code 26436-5638. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Lidocaine/tetracaine/ Phenylephrine Hcl 20%/7%/0.5%?

The NDC package code 26436-5638-1 was assigned to a 120 g in 1 CONTAINER of tetracaine; lidocaine; phenylephrine hydrochloride administered topical via ointment.

Who manufactures this product?

Lidocaine/tetracaine/ Phenylephrine Hcl 20%/7%/0.5% is manufactured by an outsourced facility and labeled by Hybrid Pharma. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 2 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hybrid Pharma with NDC product codes 26436-5624-1 and 26436-5624-1.